Literature DB >> 11786910

Interleukin-6-deficient mice develop mature-onset obesity.

Ville Wallenius1, Kristina Wallenius, Bo Ahrén, Mats Rudling, Hans Carlsten, Suzanne L Dickson, Claes Ohlsson, John-Olov Jansson.   

Abstract

The immune-modulating cytokine interleukin-6 (IL-6) is expressed both in adipose tissue and centrally in hypothalamic nuclei that regulate body composition. We investigated the impact of loss of IL-6 on body composition in mice lacking the gene encoding IL-6 (Il6-/- mice) and found that they developed mature-onset obesity that was partly reversed by IL-6 replacement. The obese Il6-/- mice had disturbed carbohydrate and lipid metabolism, increased leptin levels and decreased responsiveness to leptin treatment. To investigate the possible mechanism and site of action of the anti-obesity effect of IL-6, we injected rats centrally and peripherally with IL-6 at low doses. Intracerebroventricular, but not intraperitoneal IL-6 treatment increased energy expenditure. In conclusion, centrally acting IL-6 exerts anti-obesity effects in rodents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786910     DOI: 10.1038/nm0102-75

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  371 in total

Review 1.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

Review 2.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

3.  Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse.

Authors:  Alicia H Clementi; Allison M Gaudy; Teresa A Zimmers; Leonidas G Koniaris; Robert A Mooney
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

Review 4.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

5.  Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats.

Authors:  Kathleen S Curtis; Kelly McCracken; Enith Espinosa; Johnson Ong; Daniel J Buck; Randall L Davis
Journal:  Neurochem Res       Date:  2018-07-20       Impact factor: 3.996

6.  Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency.

Authors:  Eric P Zorrilla; Manuel Sanchez-Alavez; Shuei Sugama; Molly Brennan; Rosette Fernandez; Tamas Bartfai; Bruno Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

7.  Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Authors:  Adam Steensberg; Christian P Fischer; Massimo Sacchetti; Charlotte Keller; Takuya Osada; Peter Schjerling; Gerrit van Hall; Mark A Febbraio; Bente Klarlund Pedersen
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

Review 8.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

9.  Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation.

Authors:  Giacomo Giacovazzo; Savina Apolloni; Roberto Coccurello
Journal:  Purinergic Signal       Date:  2018-05-12       Impact factor: 3.765

10.  Interleukin-6 receptor gene 48892 A/C polymorphism is associated with metabolic syndrome in female Taiwanese adolescents.

Authors:  Chang-Hsun Hsieh; Yi-Jen Hung; Ling-I Wu; Chih-Tsueng He; Chien-Hsing Lee; Fone-Ching Hsiao; Nain-Feng Chu
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.